Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?

BMC Public Health

Adam L Cohen²  Meredith L McMorrow³  Jazmin Duque¹ 

[1] Battelle Atlanta, 2987 Clairmont NE Suite 450, Atlanta, GA 30329, USA;Influenza Program, U.S. Centers for Disease Control and Prevention-South Africa, PO Box 9536, Pretoria 0001, Republic of South Africa;U.S. Public Health Service, Rockville, MD, USA

关键词: Africa;    Recommendations;    Policy;    Drugs;    Antiviral;    Vaccine;    Influenza;   

Others  :  1161342
DOI  :  10.1186/1471-2458-14-41

 received in 2013-09-25, accepted in 2014-01-08,  发布年份 2014

【 摘 要 】

Background

Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa.

Methods

A self-administered survey was distributed among key influenza experts in 40 African countries.

Results

Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population.

Conclusions

Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely.

【 授权许可】

   
2014 Duque et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Katz MA, Schoub BD, Heraud JM, Breiman RF, Njenga MK, Widdowson MA: Influenza in Africa: uncovering the epidemiology of a long-overlooked disease. J Infect Dis 2012, 206(Suppl 1):S1-S4.
• [2]Radin JM, Katz MA, Tempia S, Talla Nzussouo N, Davis R, Duque J, Adedeji A, Adjabeng MJ, Ampofo WK, Ayele W, et al.: Influenza surveillance in 15 countries in Africa, 2006–2010. J Infect Dis 2012, 206(Suppl 1):S14-S21.
• [3]McAnerney JM, Cohen C, Moyes J, Besselaar TG, Buys A, Schoub BD, Blumberg L: Twenty-five years of outpatient influenza surveillance in South Africa, 1984–2008. J Infect Dis 2012, 206(Suppl 1):S153-S158.
• [4]Barakat A, Ihazmad H, Benkaroum S, Cherkaoui I, Benmamoun A, Youbi M, El Aouad R: Influenza surveillance among outpatients and inpatients in Morocco, 1996–2009. PLoS One 2011, 6:e24579.
• [5]Katz MA, Lebo E, Emukule G, Njuguna HN, Aura B, Cosmas L, Audi A, Junghae M, Waiboci LW, Olack B, et al.: Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural Kenya, 2007–2010. J Infect Dis 2012, 206(Suppl 1):S53-S60.
• [6]Theo A, Liwewe M, Ndumba I, Mupila Z, Tambatamba B, Mutemba C, Somwe SW, Mwinga A, Tempia S, Monze M: Influenza Surveillance in Zambia, 2008–2009. J Infect Dis 2012, 206:S173-S177.
• [7]Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, et al.: Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012, 12:687-695.
• [8]Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Simmerman JM, Gordon A, Sato M, Howie S, et al.: Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378:1917-1930.
• [9]CDC: Influenza outbreak--Madagascar, July-August 2002. MMWR Morb Mortal Wkly Rep 2002, 51:1016-1018.
• [10]WHO: Influenza outbreak in the district of bosobolo, democratic republic of the congo, november-december 2002. Wkly Epidemiol Rec 2003, 78:94-96.
• [11]Cohen C, Simonsen L, Kang JW, Miller M, McAnerney J, Blumberg L, Schoub B, Madhi SA, Viboud C: Elevated influenza-related excess mortality in South African elderly individuals, 1998–2005. Clin Infect Dis 2010, 51:1362-1369.
• [12]Fact sheet on influenza http://www.who.int/mediacentre/factsheets/fs211/en/index.html webcite
• [13]Partridge J, Kieny MP: Global production capacity of seasonal influenza vaccine in 2011. Vaccine 2013, 31:728-731.
• [14]Back to immunization surveillance, assessment and monitoring data http://www.who.int/immunization/monitoring_surveillance/en/ webcite
• [15]Palache A: Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies. Vaccine 2011, 29:9459-9466.
• [16]Third annual African network for influenza surveillance and epidemiology (ANISE) meeting https://www.team-psa.com/anise/2012/home.asp webcite
• [17]OpenEpi http://www.openepi.com webcite
• [18]The World Bank Indicators. http://data.worldbank.org/indicator webcite
• [19]Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U, Klugman K, Phillips D, Guideline Committee o, et al.: Influenza guideline for South Africa--update 2008. S Afr Med J 2008, 98:224-230.
• [20]Gupta V, Dawood FS, Muangchana C, Lan PT, Xeuatvongsa A, Sovann L, Olveda R, Cutter J, Oo KY, Ratih TS, et al.: Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008–2011. PLoS One 2012, 7:e52842.
• [21]Countries eligible for support http://www.gavialliance.org/support/apply/countries-eligible-for-support/ webcite
• [22]Gessner BD, Shindo N, Briand S: Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. Lancet Infect Dis 2011, 11:223-235.
• [23]Steffen C, Diop OM, Gessner BD, Hacen MM, Hassar M, Katz MA, Miller MA, Paget WJ, Schoub BD, Vernet G, Ndumbe PM: Afriflu--international conference on influenza disease burden in Africa, 1–2 June 2010, Marrakech, Morocco. Vaccine 2011, 29:363-369.
• [24]Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, et al.: A global pandemic influenza vaccine action plan. Vaccine 2006, 24:6367-6370.
• [25]Members of the Western Pacific Region Global Influenza S, System R: Seasonal influenza vaccine policies, recommendations and use in the world health Organization’s Western Pacific Region. West Pac Surveill Response J 2013, 4:51-59.